Alkosign Limited (BOM:543453)
India · Delayed Price · Currency is INR 54.00
-1.26 (-2.28%)
At close: Jun 19, 2026
Alkosign Revenue
In the fiscal year ending March 31, 2026, Alkosign had annual revenue of 266.98M INR, down -48.19%.
Revenue
266.98M
Revenue Growth
-42.34%
P/S Ratio
3.27
Revenue / Employee
3.26M
Employees
82
Market Cap
874.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 266.98M | -248.32M | -48.19% |
| Mar 31, 2025 | 515.31M | 158.44M | 44.40% |
| Mar 31, 2024 | 356.87M | 143.09M | 66.94% |
| Mar 31, 2023 | 213.78M | 112.17M | 110.40% |
| Mar 31, 2022 | 101.61M | -30.91M | -23.33% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ultracab (India) | 2.60B |
| GEM Enviro Management | 1.02B |
| Mercury Laboratories | 759.37M |
| Amwill Health Care | 454.92M |
| Mukesh Babu Financial Services | 240.60M |
| Assam Entrade | 126.71M |
| Radhe Developers (India) | 112.44M |
| Saumya Consultants | 98.76M |